ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. It specialises in the strategic development, management and analysis of programs that support Clinical Development - from compound selection to Phase I-IV clinical studies

In a highly fragmented industry, it is one of a small group of organisations with the capability and expertise to conduct clinical trials and development projects on either a local or global basis.

 

ICON Central Laboratories (ICL) is dedicated exclusively to central laboratory testing and the associated services for clinical trials. ICL's global network of facilities in the US, Ireland, Singapore, India and China operate with identical analytical platforms, SOPs, QC materials and reagents to support large global studies. Since our inception in the early 1990s, we have successfully managed the laboratory and associated investigator and logistical support requirements for thousands of clients in virtually every phase and therapeutic area of clinical development.